Company Filing History:
Years Active: 1999-2005
Title: Edward Jess Victoria: Innovator in Therapeutic and Diagnostic Domains
Introduction
Edward Jess Victoria is a notable inventor based in San Diego, CA. He has made significant contributions to the field of therapeutics and diagnostics, holding a total of four patents. His work focuses on innovative solutions that address critical health issues.
Latest Patents
One of Edward's latest patents involves domain 1 β2GPI polypeptides and methods of using them. This invention provides domain 1 β2GPI polypeptides, polynucleotides encoding these polypeptides, and mimetics. These polypeptides have been shown to bind to anti-cardiolipin antibodies, which are associated with various pathologies, including thrombosis and fetal loss. The polypeptides may be utilized to detect β2GPI-dependent antiphospholipid antibodies in samples. Additionally, the invention outlines methods of inducing tolerance using these polypeptides. Another significant patent focuses on aPL immunoreactive peptides, conjugates thereof, and methods of treatment for aPL antibody-mediated pathologies. This patent discloses aPL analogs that specifically bind to B cells and are useful as conjugates for treating aPL antibody-mediated diseases.
Career Highlights
Edward Jess Victoria is currently associated with La Jolla Pharmaceutical Company, where he continues to innovate in the therapeutic domain. His work has been instrumental in developing new methods and compositions for treating complex medical conditions.
Collaborations
Edward collaborates with notable colleagues, including David Matthew Marquis and David S. Jones. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Edward Jess Victoria is a prominent inventor whose work in therapeutic and diagnostic domains has the potential to significantly impact healthcare. His innovative patents and collaborations reflect his commitment to advancing medical science.